This aligns with similar study, which also found a doseresponse relationship between GLP-1 therapy duration and behavioral outcomes, including reductions in addictive behaviors [27]
The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands
Wan, S., Browning, K
By shifting dietary choices away from energy-dense, highly palatable foods toward more nutritious alternatives, GLP-1 RAs offer unique insight into the neural and behavioral mechanisms underlying compulsive consumption
A comparison of copper binding properties, copper exchange rate and redox potential between two similar naturally occurring copper-binding peptides GHK and DAHK shows that even though both bind copper in stoichiometry at a ratio of 1:1, the exchange rate of copper between DAHK peptides is very slow, while the exchange rate between GHK peptides is much faster